135 related articles for article (PubMed ID: 35151492)
1. Association of recurrent APOBEC3B alterations with the prognosis of gastric-type cervical adenocarcinoma.
Liao X; Xia X; Su W; Yan H; Ma Y; Xu L; Luo H; Liu W; Yin D; Zhang WH; Chen HN; Deng Y; Ren Z; Yu Z; Liao F; Chen K; Cao M; Zhang Y; Zhang W; Wang W; Zhao JN; Xu H; Shu Y
Gynecol Oncol; 2022 Apr; 165(1):105-113. PubMed ID: 35151492
[TBL] [Abstract][Full Text] [Related]
2. Genetic Polymorphisms Predisposing the Interleukin 6-Induced APOBEC3B-UNG Imbalance Increase HCC Risk via Promoting the Generation of APOBEC-Signature HBV Mutations.
Liu W; Wu J; Yang F; Ma L; Ni C; Hou X; Wang L; Xu A; Song J; Deng Y; Xian L; Li Z; Wang S; Chen X; Yin J; Han X; Li C; Zhao J; Cao G
Clin Cancer Res; 2019 Sep; 25(18):5525-5536. PubMed ID: 31152021
[TBL] [Abstract][Full Text] [Related]
3. Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer.
Xia S; Gu Y; Zhang H; Fei Y; Cao Y; Fang H; Wang J; Lin C; Zhang H; Li H; He H; Xu J; Li R; Liu H; Zhang W
Oncoimmunology; 2021; 10(1):1975386. PubMed ID: 34552824
[TBL] [Abstract][Full Text] [Related]
4. Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations.
Selenica P; Alemar B; Matrai C; Talia KL; Veras E; Hussein Y; Oliva E; Beets-Tan RGH; Mikami Y; McCluggage WG; Kiyokawa T; Weigelt B; Park KJ; Murali R
Mod Pathol; 2021 Jun; 34(6):1213-1225. PubMed ID: 33318584
[TBL] [Abstract][Full Text] [Related]
5. The 29.5 kb APOBEC3B Deletion Polymorphism Is Not Associated with Clinical Outcome of Breast Cancer.
Liu J; Sieuwerts AM; Look MP; van der Vlugt-Daane M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
PLoS One; 2016; 11(8):e0161731. PubMed ID: 27552096
[TBL] [Abstract][Full Text] [Related]
6. Assessment of an APOBEC3B truncating mutation, c.783delG, in patients with breast cancer.
Radmanesh H; Spethmann T; Enßen J; Schürmann P; Bhuju S; Geffers R; Antonenkova N; Khusnutdinova E; Sadr-Nabavi A; Shandiz FH; Park-Simon TW; Hillemanns P; Christiansen H; Bogdanova N; Dörk T
Breast Cancer Res Treat; 2017 Feb; 162(1):31-37. PubMed ID: 28062980
[TBL] [Abstract][Full Text] [Related]
7. The DNA Cytosine Deaminase APOBEC3B is a Molecular Determinant of Platinum Responsiveness in Clear Cell Ovarian Cancer.
Serebrenik AA; Argyris PP; Jarvis MC; Brown WL; Bazzaro M; Vogel RI; Erickson BK; Lee SH; Goergen KM; Maurer MJ; Heinzen EP; Oberg AL; Huang Y; Hou X; Weroha SJ; Kaufmann SH; Harris RS
Clin Cancer Res; 2020 Jul; 26(13):3397-3407. PubMed ID: 32060098
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of HPV E6 and APOBEC3B in Upper Urinary Tract Urothelial Carcinoma.
He L; Yang B; Jian D; Luo H; Wang D; Dai N
Dis Markers; 2022; 2022():2147494. PubMed ID: 35903294
[TBL] [Abstract][Full Text] [Related]
9. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
10. Germline APOBEC3B deletion is associated with breast cancer risk in an Asian multi-ethnic cohort and with immune cell presentation.
Wen WX; Soo JS; Kwan PY; Hong E; Khang TF; Mariapun S; Lee CS; Hasan SN; Rajadurai P; Yip CH; Mohd Taib NA; Teo SH
Breast Cancer Res; 2016 May; 18(1):56. PubMed ID: 27233495
[TBL] [Abstract][Full Text] [Related]
11. APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer.
Wang S; Jia M; He Z; Liu XS
Oncogene; 2018 Jul; 37(29):3924-3936. PubMed ID: 29695832
[TBL] [Abstract][Full Text] [Related]
12. Genomic, transcriptomic, and viral integration profiles associated with recurrent/metastatic progression in high-risk human papillomavirus cervical carcinomas.
Liu JJ; Ho JY; Lee JE; Hur SY; Yoo J; Kim KR; Ryu D; Kim TM; Choi YJ
Cancer Med; 2020 Nov; 9(21):8243-8257. PubMed ID: 33017516
[TBL] [Abstract][Full Text] [Related]
13. HPV-16/18 E6-induced APOBEC3B expression associates with proliferation of cervical cancer cells and hypomethylation of Cyclin D1.
Fan Q; Huang T; Sun X; Wang YW; Wang J; Liu Y; Ni T; Gu SL; Li YH; Wang YD
Mol Carcinog; 2021 May; 60(5):313-330. PubMed ID: 33631046
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosis.
Long X; Lu H; Cai MC; Zang J; Zhang Z; Wu J; Liu X; Cheng L; Cheng J; Cheung LWT; Shen Z; Zhou Y; Di W; Zhuang G; Yin X
Br J Cancer; 2023 Jun; 128(11):2054-2062. PubMed ID: 36997661
[TBL] [Abstract][Full Text] [Related]
15. Involvement of APOBEC3B in mutation induction by irradiation.
Saito Y; Miura H; Takahashi N; Kuwahara Y; Yamamoto Y; Fukumoto M; Yamamoto F
J Radiat Res; 2020 Nov; 61(6):819-827. PubMed ID: 32880638
[TBL] [Abstract][Full Text] [Related]
16. Somatic Genomics and Clinical Features of Lung Adenocarcinoma: A Retrospective Study.
Shi J; Hua X; Zhu B; Ravichandran S; Wang M; Nguyen C; Brodie SA; Palleschi A; Alloisio M; Pariscenti G; Jones K; Zhou W; Bouk AJ; Boland J; Hicks B; Risch A; Bennett H; Luke BT; Song L; Duan J; Liu P; Kohno T; Chen Q; Meerzaman D; Marconett C; Laird-Offringa I; Mills I; Caporaso NE; Gail MH; Pesatori AC; Consonni D; Bertazzi PA; Chanock SJ; Landi MT
PLoS Med; 2016 Dec; 13(12):e1002162. PubMed ID: 27923066
[TBL] [Abstract][Full Text] [Related]
17. Aberrantly Activated APOBEC3B Is Associated With Mutant p53-Driven Refractory/Relapsed Diffuse Large B-Cell Lymphoma.
Zhang X; Wu Z; Hao Y; Yu T; Li X; Liang Y; Li J; Huang L; Xu Y; Li X; Xu X; Wang W; Xu G; Zhang X; Lv Q; Fang Y; Xu R; Qian W
Front Immunol; 2022; 13():888250. PubMed ID: 35592333
[TBL] [Abstract][Full Text] [Related]
18. Evidence for APOBEC3B mutagenesis in multiple human cancers.
Burns MB; Temiz NA; Harris RS
Nat Genet; 2013 Sep; 45(9):977-83. PubMed ID: 23852168
[TBL] [Abstract][Full Text] [Related]
19. Acute expression of human APOBEC3B in mice results in RNA editing and lethality.
Alonso de la Vega A; Temiz NA; Tasakis R; Somogyi K; Salgueiro L; Zimmer E; Ramos M; Diaz-Jimenez A; Chocarro S; Fernández-Vaquero M; Stefanovska B; Reuveni E; Ben-David U; Stenzinger A; Poth T; Heikenwälder M; Papavasiliou N; Harris RS; Sotillo R
Genome Biol; 2023 Nov; 24(1):267. PubMed ID: 38001542
[TBL] [Abstract][Full Text] [Related]
20. The Prognostic Significance of APOBEC3B and PD-L1/PD-1 in Nasopharyngeal Carcinoma.
Feng C; Zhang Y; Huang J; Zheng Q; Yang Y; Xu B
Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):239-244. PubMed ID: 32205739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
